Surgery Partners/$SGRY

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Surgery Partners

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.

Ticker

$SGRY
Primary listing

Industry

Health Care Providers & Services

Employees

15,000

ISIN

US86881A1007

Surgery Partners Metrics

BasicAdvanced
$2.8B
-
-$1.53
1.97
-

What the Analysts think about Surgery Partners

Analyst ratings (Buy, Hold, Sell) for Surgery Partners stock.

Bulls say / Bears say

Bain Capital's proposal to acquire the remaining shares of Surgery Partners at a 21.2% premium indicates strong confidence in the company's value and potential for growth. (reuters.com)
Surgery Partners reported a 13.5% revenue increase for FY24, reaching $2.8 billion, and an 8% rise in same-facility revenue, demonstrating robust operational performance. (panabee.com)
Vanguard Group Inc. increased its stake in Surgery Partners by 2.3%, purchasing an additional 172,271 shares, reflecting institutional confidence in the company's prospects. (marketbeat.com)
Despite revenue growth, Surgery Partners reported a net loss of $168 million in FY24, significantly widening from a $12 million loss the previous year, raising concerns about profitability. (panabee.com)
The company's high debt load of $3.4 billion, with a debt-to-equity ratio of 99.38%, poses financial risks, especially in a rising interest rate environment. (forbes.com)
Recent insider selling, including CFO David T. Doherty's sale of 6,733 shares, may signal potential concerns about the company's future performance. (techdows.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

Surgery Partners Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Surgery Partners Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SGRY

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs